Explore

Rapid Read Rapid Read
AI in Mental Healthcare Requires Human Supervision to Ensure Safety and Effectiveness

AI in Mental Healthcare Requires Human Supervision to Ensure Safety and Effectiveness

A commentary in the Journal of Medical Systems argues that while human oversight is widely touted as a safeguard for artificial intelligence (AI) in medicine, it often falls short in practice. The authors, Jonas Ver Berne and Reinhilde Jacobs of KU Leuven and Karolinska Institutet, distinguish between 'cognitive oversight' and 'normative oversight.' Cognitive oversight refers to a clinician's ability to genuinely understand the AI's reasoning, data, and uncertainties. Normative oversight is the clinician's capacity to take responsibility for the AI-assisted decision. The commentary asserts that as AI systems become more complex and 'agentic' (planning multi-step actions and integrating diverse data), clinicians' cognitive oversight erodes, while their legal and moral responsibility (normative oversight) remains intact. This creates a dangerous asymmetry where accountability persists without comprehension.
Rapid Read Rapid Read
FDA Seeks Public Comment on Regulatory Framework for Generative AI-Enabled Medical Devices

FDA Seeks Public Comment on Regulatory Framework for Generative AI-Enabled Medical Devices

The FDA’s Center for Devices and Radiological Health (CDRH) has released a discussion paper titled 'Considerations for the Regulation of Generative AI-Enabled Medical Devices,' seeking public feedback on a potential regulatory framework. This paper is not a draft or final guidance but rather an invitation for comments on how to regulate generative artificial intelligence (GenAI)-enabled medical devices. It poses 26 discussion questions across key areas, including risk assessment, a competency-based approach for premarket evaluation, postmarket monitoring, foundation model device master files, and considerations for agentic AI systems. The CDRH is exploring a two-axis risk framework, similar to ISO 14971, which evaluates the activity performed by a GenAI function and the consequences of incorrect outputs. Additionally, a competency-based approach for premarket evaluation, drawing parallels from medical training and licensure, is being considered, involving non-clinical device benchmarking and clinical confi...
Trendline Trendline
Meditation Apps Offer Diverse Approaches for Mental Well-being

Meditation Apps Offer Diverse Approaches for Mental Well-being

Meditation Apps Offer Diverse Approaches for Mental Well-being
Trendline Trendline
Eight Sleep Partners with Bryan Johnson for Weekly Biological Age Tracking Feature

Eight Sleep Partners with Bryan Johnson for Weekly Biological Age Tracking Feature

Eight Sleep Partners with Bryan Johnson for Weekly Biological Age Tracking Feature
Rapid Read Rapid Read
AI and Data Analysis Advance Precision Medicine for Personalized Healthcare

AI and Data Analysis Advance Precision Medicine for Personalized Healthcare

Stratified medicine, also known as precision medicine, is evolving rapidly through the integration of artificial intelligence (AI) and advanced data analysis. This approach tailors medical treatments to individual patient characteristics, considering genetic, environmental, and lifestyle factors. AI-assisted technologies are demonstrating significant potential in various medical applications, including disease detection, risk prediction, patient stratification, prognosis assessment, and treatment planning. The analysis of multimodal health data, which encompasses medical images, electronic health records, pathological data, physiological signals, and genomic profiles, is crucial for developing effective clinical decision support systems. Despite these advancements, challenges remain in translating AI models from experimental settings into routine clinical practice. Issues such as the 'black box' nature of many AI systems, sensitivity to differences in patient populations, biased training data, and privacy ...
Rapid Read Rapid Read
U.S. Congressman Juan Ciscomani Visits GlobalMed to Discuss Telehealth Expansion for Underserved Communities

U.S. Congressman Juan Ciscomani Visits GlobalMed to Discuss Telehealth Expansion for Underserved Communities

U.S. Congressman Juan Ciscomani recently visited GlobalMed, an Arizona-based telehealth technology company. During his visit, GlobalMed's leadership team demonstrated how their virtual care solutions are expanding healthcare access. The focus of these solutions is on serving veterans, rural communities, tribal communities, and federal health systems. The company, which is veteran-owned, highlighted its commitment to improving healthcare accessibility from its base in Arizona. Congressman Ciscomani's visit underscores a continued focus on leveraging technology to address healthcare disparities across the state and for specific populations.
Trendline Trendline
Women's Health Technology Market Faces Scrutiny Over Capacity Amidst Growing Demand

Women's Health Technology Market Faces Scrutiny Over Capacity Amidst Growing Demand

Women's Health Technology Market Faces Scrutiny Over Capacity Amidst Growing Demand
Trendline Trendline
Medical Spa Industry Faces Increased Regulatory Scrutiny Amidst Rapid Growth and Patient Safety Concerns

Medical Spa Industry Faces Increased Regulatory Scrutiny Amidst Rapid Growth and Patient Safety Concerns

Medical Spa Industry Faces Increased Regulatory Scrutiny Amidst Rapid Growth and Patient Safety Concerns
Trendline Trendline
Cigna Healthcare Introduces Integrated Supplemental Benefits for High-Deductible Health Plans

Cigna Healthcare Introduces Integrated Supplemental Benefits for High-Deductible Health Plans

Cigna Healthcare Introduces Integrated Supplemental Benefits for High-Deductible Health Plans
Trendline Trendline
NexLife Expands Compounded GLP-1 Program with Microdose and Sublingual Options, Emphasizing Flat-Rate Pricing

NexLife Expands Compounded GLP-1 Program with Microdose and Sublingual Options, Emphasizing Flat-Rate Pricing

NexLife Expands Compounded GLP-1 Program with Microdose and Sublingual Options, Emphasizing Flat-Rate Pricing
Trendline Trendline
VedaBio Partners with UCP Merchant Medicine to Position CRISPR Molecular Diagnostics for Urgent Care Market

VedaBio Partners with UCP Merchant Medicine to Position CRISPR Molecular Diagnostics for Urgent Care Market

VedaBio Partners with UCP Merchant Medicine to Position CRISPR Molecular Diagnostics for Urgent Care Market
Rapid Read Rapid Read
Popular Supplements Like Turmeric, Lion's Mane, and Omega-3 Show Limited Clinical Benefits

Popular Supplements Like Turmeric, Lion's Mane, and Omega-3 Show Limited Clinical Benefits

Despite widespread popularity, several commonly used supplements, including turmeric, lion's mane mushrooms, and omega-3 fatty acids, are showing limited or disappointing benefits in clinical trials. Turmeric's key ingredient, curcumin, is often touted for anti-inflammatory and anti-cancer properties, but many original studies supporting these claims have been retracted due to flaws. Curcumin is also poorly soluble and largely excreted, making its efficacy questionable, and some high-bioavailability formulations have been linked to liver injury. Lion's mane mushrooms, marketed as cognitive enhancers, lack substantial research to support these claims, with experts calling for more evidence. Similarly, omega-3 supplements, despite the known benefits of fish consumption, have shown little to no effect on lifespan, heart health, or brain function in rigorous randomized trials and Cochrane reviews.